Minocycline HCl

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation). 

Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.

Għandna ħafna fabbriki ta 'kwalità għolja b'kooperazzjoni profonda, li jistgħu jagħtuk prodotti ta' kwalità għolja u prezzijiet kompetittivi. U nistgħu wkoll nagħtu skontijiet għal xiri bl-ingrossa. U aħna nikkooperaw ma 'ħafna kumpaniji professjonali tal-ġarr tal-merkanzija, nistgħu nwasslu prodotti b'mod sikur u bla xkiel f'idejk. Il-ħin tal-kunsinna huwa ta 'madwar 3-20 jum wara l-konferma tal-ħlas.

Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.

1. Inti fabbrika jew kumpanija kummerċjali?
Aħna kumpanija li tintegra l-industrija u l-kummerċ, li nipprovdu servizz one-stop. OEM jista 'jiġi aċċettat.

2. Inti tipprovdi kampjuni? Huwa b'xejn jew żejjed?
Kampjuni b'xejn. It-tariffa tal-merkanzija tal-kampjun trid titħallas min-naħa tiegħek.

3. Għandek xi ċertifikati relatati mal-kontroll tal-kwalità?
Ċertifikazzjoni ISO 9001:2008 biex tiġi żgurata l-kwalità.

4. X'għandi nipprovdi biex tikseb kwotazzjoni?
PLS għarrafna bit-tip ta 'prodott li għandek bżonn, kwantità tal-ordni, indirizz u rekwiżiti speċifiċi. Il-kwotazzjoni ssir għar-referenza tiegħek fil-ħin.

5. X'tip ta 'metodu ta' ħlas tippreferi? X'tip ta' termini huma aċċettati?
Termini ta ' Kunsinna Aċċettati: FOB, CFR, CIF, EXW;
Munita ta 'Ħlas Aċċettata: USD;
Tip ta' Ħlas Aċċettat: T/T,Western Union; Paypal, Assigurazzjoni tal-Kummerċ.
Lingwa Mitkellma: Ingliż.